NEXGEL
Manufacturing · Pennsylvania, United States · 11-50 Employees
View Company Info for Free
Overview
Headquarters
2150 Cabot Blvd W Ste B, Langhorne, Penn...Phone Number
(215) 702-8550Website
www.nexgel.comRevenue
$11.3 MillionStock Symbol
NXGLIndustry
ZI Rank: 1
Signal Type
Mar
Apr
May
Jun
Jul
Aug
ZI Rank
1
1
1
1
1
1
About NEXGEL
NEXGEL is a healthcare and materials science company that develops and manufactures advanced hydrogel-based patches and transdermal delivery systems used in wound care, cosmetics, and over-the-counter medical applications. The company specializes in electron-beam cross-linked hydrogel technology designed to deliver active ingredients gently to the skin without traditional chemical adhesives. Its products are used across medical, cosmetic, and consumer health markets, focusing on skin-friendly, high-water-content materials for therapeutic and commercial applications.Explore more
NEXGEL Org Chart
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is NEXGEL your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Product Launch: Get notified when NEXGEL launches new products
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Check if NEXGEL has recently received funding, and reach out quickly before it becomes old news!
Website visits: Recent activity has been detected on your website
NEXGEL, which may be a good buyer, showed buying intent in Masked Content Topic
Congratulate Masked Content for being promoted to Masked Content at NEXGEL
Check out if NEXGEL is spiking on competitors!
Earning: See what the market has to say on NEXGEL recently announced quarterly report
Click to see if NEXGEL had a recent Job posting/layoffs
Funding: Get notified immidiatlly once NEXGEL has new funding data
Recommended Actions
Find VP level buyers at NEXGEL
Find 3 more new buyers
Compare Similar Companies to NEXGEL
Compare insights from companies similar to NEXGEL, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
Company Profile Activity
Activity Insights
NEXGEL is experiencing very low activity levels compared to other companies in the Manufacturing sector.
What does this means?
NEXGEL is drawing exceptional interest within the Manufacturing industry, suggesting notable developments or strong market momentum, learn more about NEXGEL.
NEXGEL financials insights
Gather financial insights about NEXGEL, including details on funding rounds, investors, total funding, and acquisitions, to gain a comprehensive understanding of their financial strategy.
2021
Debt
$127K
2022
Stock Offering
$14.2M
2026
Stock/Share Issuance
$1.2M
NEXGEL Tech Stack
A closer look at the technologies used by NEXGEL
See more technologies
Most Recent Scoops
Lateral Move
Executive Move
Executive Moves, Lateral Move, Board of Directors
New Hire
Executive Move
Executive Moves, New Hire
Product Launch
Product Launch, Healthcare Technology, Marketing Strategy
Event
Events, Operations
Event
Events, Product Development, Medical Research
NEXGEL News & Media
NEXGEL Announces Date for Investor Update Call
LANGHORNE, Pa., Sept. 16, 2026 (GLOBE NEWSWIRE) -- NEXGEL, Inc. ("NEXGEL" or the "Company") (NASDAQ: "NXGL"), a company with a patient centric medical technology sales and marketing team working closely with clinicians to provide solutions that drive better outcomes, streamline care, and elevate the patient experience, today announced the date for the investor update call referenced in its August 17, 2026 earnings release, at which time the Company indicated it expected to host the callNEXGEL ANNOUNCES LEADERSHIP TRANSITION AND STRATEGIC REVIEW INITIATIVE
LANGHORNE, Pa., Aug. 20, 2026 (GLOBE NEWSWIRE) -- NEXGEL, Inc. ("NEXGEL" or the "Company") (NASDAQ: “NXGL”) today announced a series of leadership, governance and strategic initiatives designed to strengthen operational execution, improve liquidity, and enhance long-term shareholder value.NEXGEL Reports Second Quarter 2026 Financial Results
LANGHORNE, Pa., Aug. 17, 2026 (GLOBE NEWSWIRE) -- NEXGEL, Inc. (“NEXGEL” or the “Company”) (NASDAQ: “NXGL”), a leading provider of healthcare, beauty, and over-the-counter (OTC) products including ultra-gentle, high-water-content hydrogel products for healthcare and consumer applications, today announced its second quarter 2026 financial results for the period ending June 30, 2026.If You Invested in Nexgel Inc Wt Exp 120126 (NXGLW) - Stock Titan
$1,000 invested in NXGLW 1 years ago is worth $69 today — -93.1% total return (-93.2% CAGR). Free calculator with S&P 500 comparison.
Read more news
Top Manufacturing Companies
Top companies in Canada by revenue
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding NEXGEL
Sign Up For FreeTo access detailed company insights
NEXGEL is a healthcare and materials science company that develops and manufactures advanced hydrogel-based patches and transdermal delivery systems used in wound care, cosmetics, and over-the-counter medical applications. The company specializes in electron-beam cross-linked hydrogel technology designed to deliver active ingredients gently to the... Read More
